Porsolt is attending the European Association for Cancer Research (EACR) meeting this week in Seville, Spain.
We are presenting 2 posters describing how preclinical models assist with identifying new therapeutic options for cancer and #drugrepurposing:
P2-349 entitled: “Therapeutic potential of Fingolimod and Dimethyl Fumarate in non-small cell lung cancer preclinical models”
P2-341 entitled: “Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models”
Please feel free to reach out to Sebastien Breche and Tristan Rupp, PhD who are attending, or contact us to schedule a meeting.